Picture of GT Biopharma logo

GTBP — GT Biopharma News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Brief: Gt Biopharma Announces Gtb-3550 Trike Monotherapy Rescues And Restores Nk Cell Immune Surveillance In Relapsed/Refractory Aml And Mds Cancer Patients

April 12 (Reuters) - GT Biopharma Inc  GTBP.O :
    * GT BIOPHARMA ANNOUNCES GTB-3550 TRIKE MONOTHERAPY RESCUES
AND
RESTORES NK CELL IMMUNE SURVEILLANCE IN RELAPSED/REFRACTORY AML
AND MDS CANCER PATIENTS

Source text for Eikon:  ID:nPn6KpG9sa 
Further company coverage:  GTBP.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on GT Biopharma

See all news